Cleveland Clinic has entered a five-year partnership with PathAI to develop new pathology diagnostics.
Announced last week, the collaboration will leverage PathAI’s pathology algorithms for use in diagnostics and research, with Cleveland Clinic providing data and clinical expertise.
The company and academic medical center plan to digitize hundreds of thousands pathology specimens, linked with clinical and molecular data for analysis with PathAI’s tech platform.
“Our commitment is to provide the best possible care for our patients, and it is increasingly clear that AI-powered pathology can radically enhance diagnostic accuracy and treatment selection,” said Brian Rubin, M.D., Ph.D., chair of the Pathology and Laboratory Medicine Institute at Cleveland Clinic, in a statement. “By doing this work, we’re able to maximize the value of machine learning for our patients and fuel deeper innovation that can result in better outcomes.”
As part of the partnership, Cleveland Clinic will become an equity holder in PathAI. The terms of the agreement were not disclosed.
Founded in 2016, Boston-based PathAI offers research tools and services for pathology, using machine learning and deep learning to help life sciences companies and researchers improve diagnosis accuracy and treatment efficacy.
The company last raised $165 million in series C funding in May 2021.
“This exciting collaboration accelerates PathAI’s mission to provide precision pathology for everyone. Cleveland Clinic is the ideal partner, with its many leading clinicians, educators, and researchers who are committed to transforming patient care across disease areas,” said Andy Beck, M.D., CEO of PathAI. “We see an incredible opportunity to accelerate innovation in precise pathology and to use our strengths to bridge communities in the healthcare ecosystem including patients, biopharma, and academic research.”
Cleveland Clinic has deepened its efforts in artificial intelligence innovations over the last few years.
In January, the hospital joined Microsoft as well as eight other health and life sciences organizations, including Intermountain Healthcare, Novant Health, and the Brookings Institution, to form a coalition to develop and track AI innovations.
Executives from each organization will come together to create new AI tools and offer education about the responsible use of AI.
Cleveland Clinic also announced a 10-year partnership with IBM in March 2021 to launch a center focused on advancing healthcare and life sciences research with AI and quantum computing.